
Glimex MV 1mg/500mg/0.2mg Tablet SR
Marketer
Zivago Pharma Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimex MV 1mg/500mg/0.2mg Tablet SR
Diabex-Trio 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combined formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex-Trio should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is only one component of a comprehensive diabetes management plan, encompassing a healthy diet, regular exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to recognize its symptoms – sweating, dizziness, headache, and tremors – and how to manage them. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before commencing treatment, as it may be unsuitable. Pregnant or lactating women should consult their physician prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.
Uses of Glimex MV 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimex MV 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimex MV 1mg/500mg/0.2mg Extended-Release tablets on an empty stomach.
Common Side effects of Glimex MV 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimex MV 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimex MV 1mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.
How Glimex MV 1mg/500mg/0.2mg Tablet SR works:
The extended-release tablet, Glimex MV, contains 1mg, 500mg, and 0.2mg of three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glimex MV 1mg/500mg/0.2mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimex MV 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimex MV 1mg/500mg/0.2mg tablet is likely unsuitable for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Glimex MV 1mg/500mg/0.2mg SR tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimex MV 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation should be at a reduced dosage; the medication is contraindicated in cases of severe liver disease.
What if you forget to take Glimex MV 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a Glimex MV 1mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimex MV 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
